12-51912437-C-T
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The ENST00000550683.5(ACVRL1):c.5C>T(p.Ala2Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.081 in 1,611,008 control chromosomes in the GnomAD database, including 5,581 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000550683.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACVRL1 | NM_000020.3 | c.-5-33C>T | intron_variant | ENST00000388922.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACVRL1 | ENST00000388922.9 | c.-5-33C>T | intron_variant | 1 | NM_000020.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0770 AC: 11709AN: 152122Hom.: 487 Cov.: 32
GnomAD3 exomes AF: 0.0838 AC: 21002AN: 250560Hom.: 938 AF XY: 0.0823 AC XY: 11158AN XY: 135504
GnomAD4 exome AF: 0.0815 AC: 118853AN: 1458768Hom.: 5093 Cov.: 32 AF XY: 0.0808 AC XY: 58625AN XY: 725826
GnomAD4 genome AF: 0.0769 AC: 11710AN: 152240Hom.: 488 Cov.: 32 AF XY: 0.0764 AC XY: 5687AN XY: 74430
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 2 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 22, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at